This company focuses on the development of new drugs, particularly in the areas of immunity, metabolism, and neurological disorders. Their pipeline includes drugs like KBL-697 and KBL-693, which are in Phase 2 and Phase 1 clinical trials respectively.
| Contact Details | 700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea Biopark Building C, 7th floorTEL : 031-628-2500E-MAIL : info@kobiolabs.com |
|---|
Find out more companies
Related products
-
-
-
-
SMEBioFDNC
-
SMEALTEOGEN Inc.
ALTEOGEN Inc. is a leading bio company whose portfolio includes next-generation biobetters, biosimilars, and proprietary biologics. They are focusing on three cutting-edge areas of the industry – long-acting biobetters, proprietary antibody-drug conjugate (ADC), and antibody biosimilars with high complexity.